Skip to main content
SpringerLink
Log in

Drug- or Substance-Related Disorders

  • Chapter
  • First Online:
Psychiatric Drugs in Children and Adolescents

Abstract

The term “drug” is not employed in the International Classification of Diseases, 10th revision (ICD-10) classification (World Health Organisation 1996), which refers instead to groups of psychotropic substances, the ingestion of which – usually on a regular and medically inappropriate basis – can lead to mental disorders and behavioral abnormalities: alcohol, opioids, cannabinoids, sedatives or hypnotics, cocaine, other psychostimulants (including caffeine), hallucinogens, tobacco, and volatile solvents. Disorders arising from alcohol abuse are not discussed here, but in Chap. 10. It is difficult to accommodate so-called party drugs in these categories, so they will be discussed in a separate section.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literature

  • Abraham HD, Aldridge AM, Gogia P (1996) The psychopharmacology of hallucinogens. Neuropsychopharmacology 14:285–298

    Article  CAS  PubMed  Google Scholar 

  • American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn (DSM-5TM). American Psychiatric Publishing, Washington/London

    Google Scholar 

  • Borg L, Broe DM, Ho A, Kreek MJ (1999) Cocaine abuse sharply reduced in an effective methadone maintenance program. J Addict Dis 18:63–75

    Article  CAS  PubMed  Google Scholar 

  • Cryan JF, Bruijnzeel AW, Skjei KL, Markou A (2003) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) 168:347–358

    Article  CAS  Google Scholar 

  • De Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97:931–949

    Article  PubMed  Google Scholar 

  • Ebner R, Schreiber W, Zierer C (2004) Buprenorphine or methadone for detoxification of young opioid addicts? Psychiatr Prax 31(Suppl 1):S108–S110

    Article  PubMed  Google Scholar 

  • Faggiano F, Vigna-Taglianti F, Versino E, Lemma P (2003) Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 3:CD002208, July 21

    Google Scholar 

  • Farrell M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D, Gossop M, Strang J (1994) Methadone maintenance treatment in opiate dependence: a review. Br Med J 309:997–1001

    Article  CAS  Google Scholar 

  • Fishbain DA, Rosomoff HL, Cutler R (1993) Opiate detoxification protocols. A clinical manual. Ann Clin Psychiatry 5:53–65

    Article  CAS  PubMed  Google Scholar 

  • Gerra G, Zalmovic A, Giusti F, Moi G, Brewer C (2002) Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Addict Biol 7:385–395

    Article  CAS  PubMed  Google Scholar 

  • Hood S, O’Neil G, Hulse G (2009) The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles. J Psychopharmacol 23:401–409

    Article  CAS  PubMed  Google Scholar 

  • Hopfer CJ, Khuri E, Crowley TJ, Hooks S (2002) Adolescent heroin use: a review of the descriptive and treatment literature. J Subst Abuse Treat 23:231–237

    Article  PubMed  Google Scholar 

  • Krabbe PF, Koning JP, Heinen N, Laheij RJ, van Cauter RM, De Jong CA (2003) Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences. Addict Biol 8:351–358

    Article  CAS  PubMed  Google Scholar 

  • Kreek MJ (1996) Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid agonists. In: Kuhar JH (ed) Pharmacological aspects of drug dependence. Springer, New York, pp 487–562

    Chapter  Google Scholar 

  • Legarda JJ (1998) Ultra-rapid opiate detoxification under anaesthesia (UROD). Lancet 351:1517–1518

    Article  CAS  PubMed  Google Scholar 

  • Liechti ME (2003) Ecstasy (MDMA): pharmacology, toxicology, and management of intoxication. Dtsch Med Wochenschr 128:1361–1366

    Article  CAS  PubMed  Google Scholar 

  • Lingford-Hughes AR, Welch S, Peters L, Nutt DJ, Ball D, Buntwal N, Chick J, Crome I, Daly C, Day E, Duka T, Finch E, Law F, Marshall EJ, Munafo M, Myles J, Porter S, Raistrick D, Reed LJ, Reid A, Sell L, Sinclair J, Tyrer P, West R, Williams T, Winstock A (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 26:899–952

    Article  CAS  PubMed  Google Scholar 

  • Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, Oppenkowski T, Stokes-Lampard H, Davey Smith G (2004) Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 363:1579–1588

    Article  PubMed  Google Scholar 

  • Magura S, Rosenblum A (2001) Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med 68:62–74

    CAS  PubMed  Google Scholar 

  • Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J (2005) Comparison of pharmacological treatments for opioid-dependent adolescents. A randomized controlled trial. Arch Gen Psychiatry 62:1157–1164

    Article  CAS  PubMed  Google Scholar 

  • Mattick RP, Kimber J, Breen C, Davoli M (2008) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2:CD002207, April 23

    Google Scholar 

  • McDonough M, Kennedy N, Glasper A, Bearn J (2004) Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 75:3–9

    Article  CAS  PubMed  Google Scholar 

  • Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131–181

    Article  CAS  PubMed  Google Scholar 

  • Niederhofer H, Huber M (2004) Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results. Pharmacotherapy 24:1524–1528

    Article  CAS  PubMed  Google Scholar 

  • O’Brien CP (2005) Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66(Suppl 2):28–33

    PubMed  Google Scholar 

  • Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE (2010) Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial. Addiction 105:1616–1624

    Article  PubMed Central  PubMed  Google Scholar 

  • Preuss UW, Bahlmann M, Koller G, Soyka M (2000) Treatment of cocaine dependence. Intoxication, withdrawal and prevention of relapse. Fortschr Neurol Psychiatr 68:224–238

    Article  CAS  PubMed  Google Scholar 

  • Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso D (1998) A randomized trial of nortriptyline for smoking cessation. Arch Intern Med 158:2035–2039

    Article  CAS  PubMed  Google Scholar 

  • Reynolds PC, Jindrich EJ (1985) A mescaline associated fatality. J Anal Toxicol 9:183–184

    Article  CAS  PubMed  Google Scholar 

  • Roozen HG, de Kan R, van den Brink W, Kerkhof BJ, Geerlings PJ (2002) Dangers involved in rapid opioid detoxification while using opioid antagonists: dehydration and renal failure. Addiction 97:1071–1073

    Article  CAS  PubMed  Google Scholar 

  • Ross S, Peselow E (2009) Pharmacotherapy of additive disorders. Clin Neuropharmacol 32:277–289

    Article  CAS  PubMed  Google Scholar 

  • Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM (2000) Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 283:1303–1310

    Article  CAS  PubMed  Google Scholar 

  • Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3:CD000146, July 24

    Google Scholar 

  • Soyka M (1998) Drogen und Medikamentenabhängigkeit. Wissenschaftliche Verlagsanstalt, Stuttgart

    Google Scholar 

  • Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, Gossop M (2003) Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. Br Med J 326:959–960

    Article  Google Scholar 

  • Thomasius R, Jung M, Schulte-Markwort M et al (2008) Suchtstörungen. In: Entwicklungspsychiatrie. Biopsy-chologische Grundlagen und die Entwicklung psychischer Störungen, 2nd edn. Schattauer, Stuttgart, pp 885–918

    Google Scholar 

  • World Health Organisation (1996) Multiaxial classification of child and adolescent psychiatric disorders. The ICD – 10 classification of mental and behavioral disorders in children and adolescents. Cambridge University Press, Cambridge

    Book  Google Scholar 

  • Zepf FD, Holtmann M, Duketis E, Maier J, Radeloff D, Schiman S, Wagner A, Poustka F, Wöckel L (2009) Withdrawal syndrome after abuse of GBH-(Gamma-Hydroxybutyrate) and its physiological precursors – its relevance for child and adolescent psychiatrists. Z Kinder Jugendpsychiatr Psychother 27:413–420

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Substance Use Disorders, Treatment and Research, Psychiatric University Hospital, Selnaustr. 9, 8001, Zurich, Switzerland

    Rudolf Stohler MD

  2. Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Laboratory for Clinical Neurobiology and Therapeutic Drug Monitoring, University of Würzburg, Füchsleinstr. 15, 97080, Würzburg, Germany

    Manfred Gerlach PhD

  3. University Hospital of Psychiatry, University of Basel, Wilhelm-Klein-Strasse 27, 4012, Basel, Switzerland

    Gerhard A. Wiesbeck MD

Authors
  1. Rudolf Stohler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manfred Gerlach PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerhard A. Wiesbeck MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rudolf Stohler MD .

Editor information

Editors and Affiliations

  1. Kinder- und Jugendpsychiatrie, Universitätsklinikum Würzburg Klinik und Poliklinik, Würzburg, Germany

    Manfred Gerlach

  2. Jugendpsychiatrie und Psychotherapie, Universitätsklinikum Würzburg Klinik und Poliklinik für Kinder- und, Würzburg, Germany

    Andreas Warnke

  3. Child and Adolescent Psychiatry New York Presbyterian Hospital, New York, New York, USA

    Laurence Greenhill

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Wien

About this chapter

Cite this chapter

Stohler, R., Gerlach, M., Wiesbeck, G.A. (2014). Drug- or Substance-Related Disorders. In: Gerlach, M., Warnke, A., Greenhill, L. (eds) Psychiatric Drugs in Children and Adolescents. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1501-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1501-5_15

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1500-8

  • Online ISBN: 978-3-7091-1501-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation